There is mounting evidence that the gut microbiome has a profound impact on human health and disease. In this chapter, we discuss interactions between endocrine disrupting chemicals (EDCs) and gut microbiota. We consider how the gut microbiota, through cross-talk with the guteliver and gutebrain axes, can mediate the outcome of EDC exposure. In addition, evidence is provided for the sex-specific, transgenerational effects of early EDC exposure, primarily through disruption of the vertical transfer of maternal gut microbiota. Furthermore, the potential role of gut microbiota dysbiosis in inflammatory, autoimmune, and anxiety-related C H A P T E R 355 Endocrine Disruption and Human Health, Second Edition https://doi.org/10.1016/B978-0-12-821985-0.00015-3 © 2022 Elsevier Inc. All rights reserved. diseases caused by EDC exposure is presented. Finally, evidence is provided that gut microbiota could be considered a therapeutic target for mitigating some of the effects of EDC on human health and disease. More specifically, inherent individual differences in gut microbiota can be used as a tool in developing a personalized microbiome-modifying approach to treating EDC-induced disorders.
Endocrine Disruption and the Gut Microbiome
Kalpana D. Acharya,Abigail E. R. Parakoyi,M. Tetel
Published 2022 in Endocrine Disruption and Human Health
ABSTRACT
PUBLICATION RECORD
- Publication year
2022
- Venue
Endocrine Disruption and Human Health
- Publication date
Unknown publication date
- Fields of study
Biology, Medicine, Environmental Science
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
CITED BY
Showing 1-2 of 2 citing papers · Page 1 of 1